Joseph C. Papa - Mar 13, 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
President and CEO, Director
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Mar 13, 2024
Transactions value $
$0
Form type
4
Date filed
3/15/2024, 05:16 PM
Previous filing
Feb 29, 2024
Next filing
Jun 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EBS Employee Stock Options (Right to Buy) Award $0 +750K $0.00 750K Mar 13, 2024 Common Stock 750K $2.33 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 500,000 options to purchase shares granted under the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan and 250,000 options to purchase shares granted under the Emergent BioSolutions Inc. Inducement Plan.
F2 Vests in three equal installments beginning on the day prior to the anniversary date of the grant.